The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
- Author:
Hyunho KIM
1
;
Joonho CHO
;
Sangseok LEE
;
Yunhee LIM
;
Byunghoon YOO
Author Information
- Publication Type:Case Report
- From:Anesthesia and Pain Medicine 2022;17(1):52-56
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Residual neuromuscular blockade (RNMB) is a frequent event after general anesthesia, which can lead to serious complications, such as upper airway obstruction. Sugammadex is useful in reversing RNMB. However, its use in infants has not yet been approved by the Food and Drug Administration. Therefore, anesthesiologists can be hesitant use it, even in situations where no other choice is available.Case: A two-month-old baby presented to the hospital for umbilical polypectomy. At the end of the surgery, neostigmine was administered. Even after waiting for 30 min and injecting an additional dose of neostigmine, neuromuscular blockade was not adequately reversed. Eventually, sugammadex was administered, and spontaneous breathing returned.
Conclusions:If there were no particular causes of delayed return to spontaneous breathing in infants, RNMB should be considered and reversal with sugammadex would be useful.
